(NU/1433- 41) IngeniumAI: The Provision of Business Consultancy to Assist Commercialisation of University Research.

At IngeniumAI we aim to address the unnecessary delays in disease diagnosis. Currently the diagnosis of many diseases takes far too long. For example, to receive a diagnosis the average pulmonary hypertension (PH) patient has 5.3 GP visits and 3 referrals, taking on average 2 years, 2 months. By this point treatment options are severely limited. If left untreated the average time to mortality is only 2 years, 6 months. Delays in diagnosis of PH are estimated to cost more than £27,000 per patient in additional healthcare resources and more than £100,000 in wider economic costs. The total UK cost is more than £250m per year, most of which could be eliminated with early screening. Globally these delays cause approximately 300,000 unnecessary deaths per year. We are responding to the opportunity by developing software to automatically analyse routine CT scans to enable early screening for diseases.

The initial brief of the executive will be to:

Phase 1 Produce a viable 5 year business plan and propose a business model with full supporting financial models and forecasts;

Phase 2 Secure (venture capital and other) funding. We have been awarded £300k from Innovate UK to fund activities within the business for 1 year from January 2023. The grant is paid 3 months in arrears and we will require sourcing of operating capital from January 2023 to facilitate the grant.

Phase 3 a. Act for the company in the spin-out legal process to obtain university approval

• b.Address all company formation matters

Phase 4 a. Obtain founder academics' and University approval for appointment as CEO.

• b.Provide to the appropriate university all matters necessary for reporting requirements

Phase 5 Secure the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 4 above